With contributions from internationally recognized experts, Lung Cancer details the current management of lung cancer and reviews new therapies in development for lung cancer, with an emphasis on therapeutic exploitation of the heterogeneous nature of lung tumors at the molecular level. Coverage includes discussion of multiple new agents that have been shown to impact overall survival as well as articles covering molecular biology of lung cancer, chemotherapy regimens for lung cancer, the emergence of maintenance therapy, the complexity of radiotherapy in the chest, the impact of adjuvant chemotherapy for resected non-small cell lung cancer, surgical considerations for early-stage lung cancer, and more. This book is a valuable tool for clinicians, nurses, researchers, medical students, residents, and fellows.
Emerging Cancer Therapeutics features :- Editorial board of nationally recognized experts across the spectrum of Cancer Therapeutics
- In-depth, up-to-date expert reviews and analysis of major new developments in all areas of Cancer Therapeutics
- Issues edited by an authority in specific subject area
- Focuses on major topics in Cancer Therapeutics with in-depth articles covering advances in clinical and translational research developments, as well as clinical applications and experience
- Emphasizes multidisciplinary approaches to research and practice
表中的内容
Contents;Foreword; Preface; Contributors; Molecular Biology of Lung Cancer and Therapeutic Implications;Chemotherapy Options for Advanced Non-Small Cell Lung Cancer;Pros and Cons of Maintenance Therapy for Advanced Non-Small Cell Lung Cancer;Antiangiogenic Agents in Lung Cancer; Emerging Novel Targeted Agents for Lung Cancer; State-of-the-Art Treatment of Lung Cancer in the Elderly; Surgical Approaches to Early Stage Lung Cancer; Advances in First- and Second-Line Therapy of Small Cell Lung Cancer;Adjuvant Chemotherapy for Early Stage Non-Small Cell Lung Cancer; Advancements in Radiotherapy for Lung Cancer; Emerging Concepts in the Treatment of Epidermal Growth Factor Receptor Mutation-Positive Lung Cancer;Index
关于作者
Athanassios Argiris, MD, FACP is Professor, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
来自同一作者的更多电子书 / 编辑
145,745 此类电子书
